Clinicopathological Factors in Relation to HER2 Status in Metastatic Gastric Cancer: A Retrospective Observational StudyMustafa GÜRBÜZa, İzzet DOĞANb, Erman AKKUŞc, İbrahim KARADAĞd, Serdar KARAKAYAd,Cihan EROLe, Ramazan ACARf, Mert KARAOĞLANc, Elif Berna KÖKSOYa, Berna SAVAŞg, Mehmet Ali Nahit ŞENDURe, Didem TAŞTEKİNb, Nuri KARADURMUŞf, Ömür Berna ÇAKMAK ÖKSÜZOĞLUd, Filiz ÇAY ŞENLERaaDivision of Medical Oncology, Ankara University Faculty of Medicine, Ankara, TURKEY
bDivision of Medical Oncology, İstanbul University Faculty of Medicine, İstanbul, TURKEY
cDepartment of Internal Medicine, Ankara University Faculty of Medicine, Ankara, TURKEY
dDivision of Medical Oncology, University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, TURKEY
eDivision of Medical Oncology, Yıldırım Beyazıt University Faculty of Medicine, Ankara, TURKEY
fDivision of Medical Oncology, University of Health Sciences Gülhane Training and Research Hospital, Ankara, TURKEY
gDepartment of Pathology, Ankara University Faculty of Medicine, Ankara, TURKEYDOI: 10.37047/jos.2021-86554 Sayfalar: 14 - 19 1552 Viewed.
Investigation of Regorafenib Efficacy in Patients with Metastatic Colorectal Carcinoma in Relation to the Delivered Dose Intensity/Body Surface AreaKadir ESERa, Emel SEZERa, Vehbi ERÇOLAKa, Ali İNALb, Alper ATAc,
Hakan BASIRd, Mustafa BERKEŞOĞLUeaDepartment of Medical Oncology, Mersin University Faculty of Medicine, Mersin, Türkiye
bClinic of Medical Oncology, Mersin Training and Research Hospital, Mersin, Türkiye
cClinic of Medical Oncology, Mersin Medical Park Hospital, Mersin, Türkiye
dDepartment of Internal Medicine, Mersin University Faculty of Medicine, Mersin, Türkiye
eDepartment of General Surgery, Mersin University Faculty of Medicine, Mersin, TürkiyeDOI: 10.37047/jos.2021-87466 Sayfalar: 34 - 42 1396 Viewed.
By 2022, Cancer is Now a More Chronic Disease with Chronic Difficulties to Go Along with ItAhmet Taner SÜMBÜLa, Ali Murat SEDEFb, Cengiz KARAÇİNc, Cemil BİLİRd,
Baran AKAGÜNDÜZeaDivison of Medical Oncology, Başkent University Adana Dr. Turgut Noyan Application and Research Center-Yüreğir Hospital,
Adana, Türkiye
bClinic of Medical Oncology, Private Medline Adana Hospital, Adana, Türkiye
cDivision of Medical Oncology, University of Health Sciences Abdurrahman Yurtaslan Ankara Oncology Health Application and
Research Center, Ankara, Türkiye
dDivision of Medical Oncology, İstinye University Hospital VM Medical Park Pendik, İstanbul, Türkiye
eDivison of Medical Oncology, Erzincan Binali Yıldırım University Mengücek Gazi Training and Research Hospital, Erzincan, TürkiyeDOI: 10.37047/jos.2022-90068 Sayfalar: 1 - 6 1347 Viewed.
The Real-Life Efficacy of the Second Line Treatment Strategy in Advanced Pancreas CancerMutlu HIZALa, Mehmet Ali Nahit ŞENDURb, Burak BİLGİNb, Ebru KARCI GÜNERc,
Muhammed Bülent AKINCIb, Yakup ERGÜNa, Ece ESİNd, Elif Berna KÖKSOYe,
Ahmet SEZERf, Nuriye ÖZDEMİRg, Berna ÖKSÜZOĞLUd, Bülent YALÇINb,
Güngör UTKANe, Yüksel ÜRÜNeaClinic of Medical Oncology, Ankara City Hospital, Ankara, Türkiye
bDivision of Medical Oncology, Ankara Yıldırım Beyazıt University Faculty of Medicine, Ankara, Türkiye
cDivision of Medical Oncology, Medipol University Faculty of Medicine, İstanbul, Türkiye
dDivision of Medical Oncology, University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Health Application and Research Center, Ankara, Türkiye
eDivision of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Türkiye
fDivision of Medical Oncology, Başkent University Faculty of Medicine, Adana, Türkiye
gDivision of Medical Oncology, Gazi University Faculty of Medicine, Ankara, TürkiyeDOI: 10.37047/jos.2022-88853 Sayfalar: 69 - 75 1115 Viewed.
Survival Analysis of Patients with Triple-Negative Breast Cancer: A Single-Center ExperienceAkif DOĞANa, Murat AYHANbaDepartment of Medical Oncology, Health Science University Kartal Dr. Lütfi Kırdar City Hospital, İstanbul, Türkiye
bDepartment of Medical Oncology, Adıyaman Training and Research Hospital, Adıyaman, TürkiyeDOI: 10.37047/jos.2022-89749 Sayfalar: 94 - 99 955 Viewed.
Benefits and Toxicity of Taxane Addition to Platinum- Fluoropyrimidine Combination in Gastric Cancer Patients with Peritoneal MetastasisTülay KUŞa, Nuriye YILDIRIM ÖZDEMİRb, Gökmen AKTAŞc, Osman SÜTÇÜOĞLUb,
Ülkü YALÇINTAŞ ARSLANd, Merve DİRİKOÇe, Fatih KÖSEf, Gülsüm AKKUŞg,
Havva YEŞİL ÇINKIRa, Ahmet ÖZETbaDepartment of Medical Oncology, Gaziantep University Faculty of Medicine, Gaziantep, Türkiye
bDepartment of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Türkiye
cClinic of Medical Oncology, Medical Park Gaziantep Hospital, Gaziantep, Türkiye
dClinic of Medical Oncology, Ankara Oncology Training and Research Hospital, Ankara, Türkiye
eDepartment of Medical Oncology, Ankara Numune Education and Research Hospital, Ankara, Türkiye
fDepartment of Medical Oncology, Başkent University Faculty of Medicine, Adana, Türkiye
gDepartment of Internal Medicine, Kahramanmaraş Sütçü İmam University Faculty of Medicine, Kahramanmaraş, TürkiyeDOI: 10.37047/jos.2022-90537 Sayfalar: 127 - 134 995 Viewed.
Prognostic Value of Androgen Receptor Expression in Premenopausal Women with Estrogen Receptor-Positive Breast CancerHasan Çağrı YILDIRIMa, Meral ÜNERb, Tuğba YILDIRAN ÖZMENc, Elvin CHALABIYEVa,
Deniz Can GÜVENa, Fatih KUŞa, Arif AKYILDIZa, Feride YILMAZa, Serkan YAŞARa,
Yasemin EVLENDİc, Ömer DİZDARa, Şuayib YALÇINa, Ayşegül ÜNERb, Sercan AKSOYaaDivision of Medical Oncology, Hacettepe University Institute of Cancer, Ankara, Türkiye
bDepartment of Pathology, Hacettepe University Faculty of Medicine, Ankara, Türkiye
cDepartment of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, TürkiyeDOI: 10.37047/jos.2022-94227 Sayfalar: 33 - 37 847 Viewed.
Prognostic Factors Associated with Locally Advanced Gastric Cancer in Patients Treated with Adjuvant ChemotherapyHasan Çağrı YILDIRIMa, Deniz Can GÜVENa, Elvin CHALABIYEVa, Hakan TABANa,
Feride YILMAZa, Serkan YAŞARa, Fatih KUŞa, Arif AKYILDIZa, Süleyman Çağın GÜRBÜZb, Hüseyin SAYINb, Gözde KAVGACIa, Şuayib YALÇINa, Ömer DİZDARaaDepartment of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Türkiye
bDepartment of Internal Medicine, Hacettepe University Medical School, Ankara, TürkiyeDOI: 10.37047/jos.2022-92230 Sayfalar: 143 - 147 1024 Viewed.
Sleep Quality Analysis in Metastatic Breast Cancer Patients Receiving Cyclin-Dependent Kinase 4-6 InhibitorÖzgecan DÜLGARa, Sevgi FERİKb, Seval AYc, Ertuğrul BAYRAMd, Teoman ŞAKALARaaClinic of Medical Oncology, Kahramanmaraş Necip Fazıl City Hospital, Kahramanmaraş, Türkiye
bClinic of Medical Neurophysiology, Kahramanmaraş Necip Fazıl City Hospital, Kahramanmaraş, Türkiye
cClinic of Medical Oncology, Balıkesir Atatürk City Hospital, Balıkesir, Türkiye
dDivision of Medical Oncology, Çukurova University Faculty of Medicine, Adana, TürkiyeDOI: 10.37047/jos.2022-91240 Sayfalar: 113 - 118 1067 Viewed.
Ischemia-Modified Albumin and Thiol-Disulfide Homeostasis in Metastatic Pancreatic CancerSelin AKTÜRK ESENa, Esra FIRAT OĞUZb, Yakup ERGÜNc, Denizcan HASTÜRKd,
Murat BARDAKÇIa, Gökhan UÇARa, Mehmet Ali Nahit ŞENDURa, İhsan ATEŞd, Özcan ERELb, Doğan UNCUaaClinic of Medical Oncology, Ankara City Hospital, Ankara, Türkiye
bClinic of Medical Biochemistry, Ankara City Hospital, Ankara, Türkiye
cClinic of Medical Oncology, Batman Training and Research Hospital, Batman, Türkiye
dClinic of Internal Diseases, Ankara City Hospital, Ankara, TürkiyeDOI: 10.37047/jos.2022-93441 Sayfalar: 148 - 156 985 Viewed.
Intravesical Bacillus Calmette-Guérin Reduces Lung Involvement in COVID-19 in Patients with Bladder CancerMehmet Serkan ÖZKENTa, Yunus Emre GÖGERb, Nurullah ALTINKAYAb, Mehmet ARTAÇcaClinic of Urology, Konya City Hospital, Konya, Türkiye
bDepartment of Urology, Necmettin Erbakan University Meram Faculty of Medicine, Konya, Türkiye
cDivision of Medical Oncology, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TürkiyeDOI: 10.37047/jos.2022-91733 Sayfalar: 135 - 142 682 Viewed.